Aicaigou LogoAicaigou LogoB2B WikiIndustrial Encyclopedia

Human Microglia

Updated: 2026-07-23

Overview

Human microglial cells are resident macrophages of the central nervous system, accounting for 10–15% of all CNS cells. They originate from myeloid progenitors during embryogenesis and play critical roles in brain homeostasis, immune defense, and tissue repair. Unlike peripheral macrophages, microglia exhibit unique molecular signatures and rapid responsiveness to CNS disturbances. These cells are pivotal in both health and disease, regulating synaptic pruning during development and contributing to neuroinflammation in conditions like multiple sclerosis or amyotrophic lateral sclerosis (ALS). Their dual role as protectors and potential aggressors in neurodegeneration makes them a focal point of biomedical research.

Key Features

匙形古柏线虫探针法荧光定量PCR试剂盒稳定性高规格齐全售后无忧上海谷研实业有限公司

Microglial cells are characterized by their highly ramified morphology in resting states, which transforms into an amoeboid shape upon activation. They express markers such as Iba1, TMEM119, and CD11b, aiding their identification. Their functional plasticity allows them to switch between pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes, modulating neural environments. Advanced imaging techniques reveal their dynamic surveillance behavior, where processes continuously scan the CNS for damage. Their phagocytic capacity clears apoptotic neurons, protein aggregates (e.g., beta-amyloid), and infectious agents. Additionally, microglia secrete cytokines (e.g., TNF-α, IL-6) and growth factors (e.g., BDNF), influencing neuronal survival and synaptic plasticity.

商家经验真实案例 · 安全可信
细胞是微型机器吗
本文探讨细胞是否可以被视为微型机器,从结构、功能和行为三个维度分析细胞与机器的相似性与差异性,揭示生命科学的奇妙复杂性。

Application Areas

In research, human microglial cells are employed to study neuroinflammatory pathways, model neurodegenerative diseases, and test neuroprotective therapeutics. Immortalized cell lines (e.g., HMC3) and primary cells derived from postmortem tissue or iPSCs are common tools. These models help elucidate mechanisms in Alzheimer’s disease, where microglia interact with tau tangles and amyloid plaques. Pharmaceutical industries use microglia to screen drugs targeting neuroinflammation or to assess toxicity. Emerging applications include engineered microglia for gene therapy and their role in brain tumor microenvironments (e.g., glioblastoma). Ethical and logistical challenges persist in sourcing human-primary microglia, driving demand for reliable alternatives like 3D organoid co-cultures.

Precautions

牛组胺(HIS)elisa试剂盒 酶联免疫吸附测定 生物试剂操作简单上海轩泽康生物有限公司

Working with human microglial cells requires stringent protocols to maintain viability and functionality. Primary cells are sensitive to oxygen levels, pH shifts, and serum batches, necessitating optimized culture media (e.g., supplemented with GM-CSF or IL-34). Contamination risks are high due to their phagocytic nature, so sterile techniques are critical. Ethical approval is mandatory for human-derived samples, and donor variability (age, health status) can affect reproducibility. Researchers must validate cell identity via flow cytometry (e.g., CD45, P2RY12) and monitor activation states to avoid skewed results. Cryopreservation may reduce functionality, so fresh isolates are preferred for certain assays.

商家经验真实案例 · 安全可信
小麦除草剂使用全攻略
本文详解小麦除草剂喷洒后多久见效,以及遇雨后是否需要重喷。从药液吸收、天气影响等角度,助你科学使用除草剂,保障小麦健康生长。

B2B Procurement Guide

When procuring human microglial cells, prioritize suppliers with certifications (e.g., ISO 13485) and detailed cell lineage documentation. Commercial providers offer primary cells, iPSC-derived microglia, or immortalized lines, each with trade-offs in cost and biological relevance. Primary cells typically range from $1,000–$3,000 per million cells, while cell lines are more economical but may lack physiological complexity. Key selection criteria include batch-to-batch consistency, marker expression profiles (e.g., CX3CR1 positivity), and additional services like CRISPR editing or pre-activation. For large-scale studies, inquire about bulk discounts or licensing agreements. Always request viability data (>90% for primary cells) and ensure compliance with institutional biosafety committees for handling human-derived materials.

Related Manufacturers